Figure 4From: BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition Individual and mean creatinine course of patients with BK-viremia under different treatment strategies (Figure 4 A + B). Individual and mean creatinine course of patients with PyVAN under different treatment strategies ( Figure 4 C + D ).Back to article page